相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hexamoll® DINCH and DPHP metabolites in urine of children and adolescents in Germany. Human biomonitoring results of the German Environmental Survey GerES V, 2014-2017
Gerda Schwedler et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2020)
Metabolism and urinary excretion kinetics of di(2-ethylhexyl) adipate (DEHA) in four human volunteers after a single oral dose
Alexandra Nehring et al.
TOXICOLOGY LETTERS (2020)
Well-tempered MCMC simulations for population pharmacokinetic models
Frederic Y. Bois et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2020)
Internal exposure of young German adults to di(2-propylheptyl) phthalate (DPHP): Trends in 24-h urine samples from the German Environmental Specimen Bank 1999-2017
Christoph Schmidtkunz et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2019)
Trends in characteristics of 24-h urine samples and their relevance for human biomonitoring studies-20 years of experience in the German Environmental Specimen Bank
Dominik Lermen et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2019)
Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop
Corie A. Ellison et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
Development, Testing, Parameterization, and Calibration of a Human Physiologically Based Pharmacokinetic Model for the Plasticizer, Hexamoll® Diisononyl-Cyclohexane-1, 2-Dicarboxylate Using In Silico, In Vitro, and Human Biomonitoring Data
Kevin McNally et al.
FRONTIERS IN PHARMACOLOGY (2019)
In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds
Eric Fabian et al.
ARCHIVES OF TOXICOLOGY (2019)
Single ingestion of di-(2-propylheptyl) phthalate (DPHP) by male volunteers: DPHP in blood and its metabolites in blood and urine
D. Klein et al.
TOXICOLOGY LETTERS (2018)
New HBM values for emerging substances, inventory of reference and HBM values in force, and working principles of the German Human Biomonitoring Commission
Petra Apel et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2017)
httk: R Package for High-Throughput Toxicokinetics
Robert G. Pearce et al.
Journal of Statistical Software (2017)
Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications
Alicia Paini et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Biological Monitoring Without Limits
John Cocker et al.
ANNALS OF WORK EXPOSURES AND HEALTH (2017)
Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery
N. Gobeau et al.
PHARMACEUTICAL RESEARCH (2016)
Di-(2-propylheptyl) phthalate (DPHP) and its metabolites in blood of rats upon single oral administration of DPHP
D. Klein et al.
TOXICOLOGY LETTERS (2016)
Bis-(2-propylheptyl)phthalate (DPHP) metabolites emerging in 24 h urine samples from the German Environmental Specimen Bank (1999-2012)
A. Schuetze et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2015)
Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A
Xiaoxia Yang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
The application of global sensitivity analysis in the development of a physiologically based pharmacokinetic model for m-xylene and ethanol co-exposure in humans
George D. Loizou et al.
FRONTIERS IN PHARMACOLOGY (2015)
Derivation of an oral reference dose (RfD) for the plasticizer, di-(2-propylheptyl)phthalate (Palatinol® 10-P)
Virunya S. Bhat et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
A Short-term In Vivo Screen Using Fetal Testosterone Production, a Key Event in the Phthalate Adverse Outcome Pathway, to Predict Disruption of Sexual Differentiation
Johnathan R. Furr et al.
TOXICOLOGICAL SCIENCES (2014)
PopGen: A virtual human population generator
Kevin McNally et al.
TOXICOLOGY (2014)
Urinary metabolite excretion after oral dosage of bis(2-propylheptyl) phthalate (DPHP) to five male volunteers - Characterization of suitable biomarkers for human biomonitoring
Gabriele Leng et al.
TOXICOLOGY LETTERS (2014)
Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method
Patrick Poulin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Metabolism of di (2-ethylhexyl) phthalate (DEHP): comparative study in juvenile and fetal marmosets and rats
Yoshimasa Kurata et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2012)
Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl) phthalate in blood and of DEHP metabolites in urine of male volunteers after single ingestion of ring-deuterated DEHP
Winfried Kessler et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Reconstruction of Exposure to m-Xylene fromHuman Biomonitoring Data Using PBPKModelling, Bayesian Inference, andMarkov ChainMonte Carlo Simulation
Kevin McNally et al.
JOURNAL OF TOXICOLOGY (2012)
Assessing exposure to phthalates - The human biomonitoring approach
Matthias Wittassek et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2011)
Human biomonitoring as a pragmatic tool to support health risk management of chemicals - Examples under the EU REACH programme
Peter J. Boogaard et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
A workflow for global sensitivity analysis of PBPK models
Kevin McNally et al.
FRONTIERS IN PHARMACOLOGY (2011)
MEGen: a physiologically based pharnnacokinetic model generator
George Loizou et al.
FRONTIERS IN PHARMACOLOGY (2011)
Biomonitoring for occupational health risk assessment (BOHRA) Introduction
Maurizio Manno et al.
TOXICOLOGY LETTERS (2010)
Calculation of Molecular Lipophilicity: State-of-the-Art and Comparison of Log P Methods on More Than 96,000 Compounds
Raimund Mannhold et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Phthalates: metabolism and exposure
Matthias Wittassek et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2008)
Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: The first steps
George Loizou et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2008)
Quantitative interpretation of human biomonitoring data
Harvey J. Clewell et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
General approach for the calculation of tissue to plasma partition coefficients
Walter Schmitt
TOXICOLOGY IN VITRO (2008)
Characterizing uncertainty and variability in physiologically based pharmacokinetic models: State of the science and needs for research and implementation
Hugh A. Barton et al.
TOXICOLOGICAL SCIENCES (2007)
Evaluation of physiologically based pharmacokinetic models for use in risk assessment
Weihsueh A. Chiu et al.
JOURNAL OF APPLIED TOXICOLOGY (2007)
Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono (2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets
W Kessler et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Substrate depletion approach for determining in vitro metabolic clearance: Time dependencies in hepatocyte and microsomal incubations
HM Jones et al.
DRUG METABOLISM AND DISPOSITION (2004)
Toxicokinetic modeling and its applications in chemical risk assessment
ME Andersen
TOXICOLOGY LETTERS (2003)
分享论文
